Genotype of an individual single nucleotide polymorphism regulates DNA methylation at the TRPC3 alternative promoter |
| |
Authors: | Martin-Trujillo Alex Iglesias-Platas Isabel Coto Eliecer Corral-Juan Marc San Nicolás Hector Corral Jordi Volpini Victor Matilla-Due?as Antoni Monk David |
| |
Affiliation: | Cancer Epigenetic and Biology Program, Institut d'Investigació Biomedica de Bellvitge, Hospital Duran i Reynals, Barcelona, Spain. |
| |
Abstract: | A fundamental challenge in the post-genomics era is to understand how genetic variants can influence phenotypic variability and disease. Recent observations from a number of studies have highlighted a mechanism by which common genetic polymorphisms can influence DNA methylation, a major epigenetic silencing mechanism. We report that the alternative promoter of the human TRPC3 gene is regulated by allelic DNA methylation, dictated by the genotype of a single base pair polymorphism, rs13121031 located within the promoter CpG island. The common G allele is associated with high levels of methylation, while the less prevalent C allele is unmethylated. This methylation profile is observed in many tissue types, despite the expression of?TRPC3?being restricted to brain and heart.?TRPC3?is prominently expressed in the hindbrain, and a heterozygous brain sample showed modest skewing according to the allelic methylation, with preferential expression from the C allele. The?TRPC3?gene encodes a transient receptor potential channel that has been implicated in cerebellar ataxia and heart hypertrophy. The genotype-frequencies of rs13121031 were determined in cohorts of ataxia patients and in individuals with cardiac hypertrophy. These analyses revealed a statistical trend for the rare unmethylated homozygous C genotype to be present at a higher frequency in idiopathic ataxia patients (Fisher's test p=0.06), but not in those patients with known mutations (Fisher's test p=0.55) or in individuals with heart disease (Fisher's test p=0.807), when compared to a control population. Our results suggest that the?TRPC3?alternative promoter is a methylation quantitative-trait locus that may be involved in modulating the ataxia phenotype. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|